Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Technology Performs Rapid Biofluid Analysis Using Single Droplet

By LabMedica International staff writers
Posted on 04 Dec 2025

Diagnosing disease typically requires milliliters of blood drawn at clinics, depending on needles, laboratory infrastructure, and trained personnel. More...

This process is often painful, resource-intensive, and inaccessible in many regions. Existing workflows overlook the rich diagnostic information embedded in the physical changes that biofluids undergo as they dry. Now, researchers have developed an automated imaging and machine-learning system that analyzes how tiny droplets of blood and other fluids dry to distinguish normal from abnormal samples.

The automated system, developed by researchers at the University of Tokyo (Tokyo, Japan), reduces reliance on traditional phlebotomy and expensive consumables by using microscopic imaging to observe biofluid droplets drying in real time. It eliminates the need for specialized diagnostic equipment by using a simple brightfield microscope with a 4x objective lens and a digital camera.

During the drying process, droplets undergo shape changes and internal pattern evolution driven by the movement of proteins, cells, and other biomolecules. These dynamic structural changes are captured frame by frame and then interpreted by a machine-learning algorithm trained to identify disease-associated abnormalities. Because the method relies on naturally occurring drying behaviors, it can also analyze saliva and urine without additional tools.

The research team demonstrated that time-evolving droplet images provide richer diagnostic information than solely examining the final dried pattern. Their machine-learning models accurately distinguished healthy from abnormal biofluid samples across multiple conditions, including diabetes, influenza, and malaria. In validation experiments, published in Science Advances, the researchers confirmed that the real-time drying profile carries a unique signature of the fluid’s composition.

This proof-of-concept work shows how drying-based imaging can serve as a rapid, low-cost diagnostic platform suitable for global deployment, especially in low-resource settings. By relying on tiny droplets instead of venous blood draws, the method enables broader screening, improves accessibility, and reduces medical waste. The researchers envision a portable device or mobile-based workflow that could extend laboratory-grade insights to populations without access to traditional testing. Future work aims to transform the system into a practical point-of-care health-screening tool.

“Such a tool could make health monitoring faster, more affordable and more accessible, especially in communities with limited access to laboratory testing. Ultimately, our goal is to bring laboratory-level insights to the point of care, enabling early detection and preventive health care for everyone,” said Amalesh Gope, co-author of the study.

Related Link
University of Tokyo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.